Shanhu Hu

Senior Scientist, Syros Pharmaceuticals Inc., Cambridge, Massachusetts

Biology lead in small molecule oncology preclinical development project targeting CDK12/13 and CDK7, responsible for target validation, compound structure-activity relationships (SAR) optimization, novel cellular assays development, mechanism of action (MOA) study design, in vivo PK/PD/efficacy study design, biomarker discovery, and combination treatment strategy development.